Skip to main content
Premium Trial:

Request an Annual Quote

Viaken Lassoes Sun to Co-Develop and Co-Distribute New Informatics Suite

SAN DIEGO, Oct. 26 – Sun Microsystems and Viaken Systems have signed a preliminary agreement to develop and market a new suite of Viaken products, GenomeWeb  has learned on Friday. 

The potential deal, which is open-ended and non-exclusive, is anticipated to close in the current quarter, a Viaken spokesman said at the 13th annual Genome Sequencing and Analysis Conference, held here through Sunday.

The collaboration calls for Sun, of Cary, NC, to help Viaken develop and sell a new line of informatics products, called Paragon, atop Sun’s E series hardware, said Michael Provance, Viaken’s vice president of discovery solutions. The computer giant will also build a marketing foundation for Viaken, a Sun spokeswoman said.

The company plans to sell the suite in the United States, Europe, and Japan. It has not yet been determined which company will be responsible for the different regions, although Viaken, which is based in Gaithersburg, Md., with offices in the UK, will be the primary distributor.

Provance said that the company hopes to launch the first product in the suite, a genomic-discovery platform, in the first quarter of 2002. Other product installments, which will be rolled out through 2003, will include tools for data visualization, data mining, and project management.

Financial details of the partnership were not disclosed.

“Sun has got the architecture we need to get this done,” Provance said at his booth four aisles from Sun’s. “This is the beginning of a much larger relationship.”

He added that Viaken has several other deals lined up for closure in either the current or next quarter. 

In July,  Viaken partnered with e-science platform provider InforSense  to market and distribute its large-scale genomic analysis and drug-discovery platform. 

As GenomeWeb  reported, the platform, called the Kensington Discovery Edition, was developed by Copenhagen-based InforSense as networked-based software for data mining and analysis. 

Terms of that agreement were not disclosed.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.